On June 3, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. On the same day, he sold 11,625 shares in an open market transaction at a price of $10.2972 per share, resulting in a total market value of $119,704.95 for the disposed shares. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 3,700 shares.

On June 3, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. On the same day, he sold 11,625 shares in an open market transaction at a price of $10.2972 per share, resulting in a total market value of $119,704.95 for the disposed shares. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 3,700 shares.